This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB24 program. The $3,268.08 award is for the supply of a 0.5mL syringe containing 0.06% VisionBlue solution. The order does not have a set-aside designation.
DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to support the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. Through this contract vehicle and other prime vendor agreements, DMS provides both routine and specialized medications, including branded and generic prescription drugs, over-the-counter items, biologics, and medical consumables, to DoD and Department of Veterans Affairs (VA) medical facilities.
Generated 12/23/24, 2:48 PM